Follow the Fractyl Health, Inc. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Market capitalisation: €126.1m. The latest transaction was disclosed on 11 June 2026 (Acquisition). Among the most active insiders: Rajagopalan Harith. The full history is accessible without an account.
27
Insider Decl.
n/a
Thresholds
€95,216
9 ops.
Buy Volume
n/a
n/a
Sell Volume
41Σ signal
Buys €95,216n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Fractyl Health, Inc. is a company focused on developing innovative solutions for the treatment of metabolic diseases. It specializes in the research and commercialization of advanced medical technologies.